MedTrace Logo

Feasibility Study of a New Immunoglobulin E (IgE) Assay Method

NCT04751760 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1376

Last updated 2026-03-19

No results posted yet for this study

Summary

The main objective is to study the feasibility of a new specific IgE assay using a bioluminescence technique in a pediatric and adult allergic population. For this, we will collect blood, and urine during a blood test scheduled for the follow-up of the patient.

Conditions

  • Allergy and Immunology

Interventions

BIOLOGICAL

collection of blood and urine

blood and urine will be collected during a blood test scheduled for the follow-up of the patient

Sponsors & Collaborators

  • University Hospital, Toulouse

    lead OTHER

Principal Investigators

  • Marine Michelet, MD · University Hospital, Toulouse

Eligibility

Min Age
6 Months
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-20
Primary Completion
2026-04-20
Completion
2026-04-20

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04751760 on ClinicalTrials.gov